| Name | 3-(5-methyl-1,3,4-oxadiazol-2-yl)aniline |
|---|---|
| Synonyms |
3-(5-methyl-[1,3,4]oxadiazol-2-yl)phenylamine
3-(5-methyl-1,3,4-oxadiazol-2-yl) benzenamine |
| Molecular Formula | C9H9N3O |
|---|---|
| Molecular Weight | 175.18700 |
| Exact Mass | 175.07500 |
| PSA | 64.94000 |
| LogP | 2.20840 |
| HS Code | 2934999090 |
|---|
|
~%
122733-40-8 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2007/48771 A1, 2007 ; Location in patent: Page/Page column 55 ; WO 2007/048771 A1 |
|
~%
122733-40-8 |
| Literature: Warner-Lambert Company Patent: US4824843 A1, 1989 ; |
|
~%
122733-40-8 |
| Literature: JOHNSON and JOHNSON Patent: WO2004/101533 A1, 2004 ; Location in patent: Page 91 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |